- Home
- ARVN vs CNCK Comparison
ARVN vs CNCK Comparison
Compare ARVN & CNCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- CNCK
- Stock Information
- Founded
- ARVN 2015
- CNCK 2012
- Country
- ARVN United States
- CNCK Netherlands
- Employees
- ARVN N/A
- CNCK N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- CNCK
- Sector
- ARVN Health Care
- CNCK
- Exchange
- ARVN Nasdaq
- CNCK NYSE
- Market Cap
- ARVN 1.2B
- CNCK N/A
- IPO Year
- ARVN 2018
- CNCK N/A
- Fundamental
- Price
- ARVN $7.02
- CNCK $4.95
- Analyst Decision
- ARVN Buy
- CNCK Buy
- Analyst Count
- ARVN 13
- CNCK 1
- Target Price
- ARVN $34.42
- CNCK $10.00
- AVG Volume (30 Days)
- ARVN 3.5M
- CNCK 33.6K
- Earning Date
- ARVN 05-06-2025
- CNCK 05-16-2025
- Dividend Yield
- ARVN N/A
- CNCK N/A
- EPS Growth
- ARVN N/A
- CNCK N/A
- EPS
- ARVN N/A
- CNCK N/A
- Revenue
- ARVN $263,399,999.00
- CNCK $2,354,350,618.00
- Revenue This Year
- ARVN N/A
- CNCK N/A
- Revenue Next Year
- ARVN $7.99
- CNCK N/A
- P/E Ratio
- ARVN N/A
- CNCK N/A
- Revenue Growth
- ARVN 235.54
- CNCK 57.02
- 52 Week Low
- ARVN $6.88
- CNCK $4.75
- 52 Week High
- ARVN $41.34
- CNCK $14.99
- Technical
- Relative Strength Index (RSI)
- ARVN 23.50
- CNCK N/A
- Support Level
- ARVN $8.51
- CNCK N/A
- Resistance Level
- ARVN $9.17
- CNCK N/A
- Average True Range (ATR)
- ARVN 0.55
- CNCK 0.00
- MACD
- ARVN -0.05
- CNCK 0.00
- Stochastic Oscillator
- ARVN 5.24
- CNCK 0.00
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.